Authors
Loading...
Preclinical study reveals bone marrow immune remodeling and myeloid expansion in MYCN-driven neuroblastoma mice, highlighting FABP4-positive macrophages as potential immunotherapeutic targets.
Embaie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: